When SARS-CoV-2 induces the activation of the RAAS system, it triggers the depletion of ACE2 on the cell surface, increasing angiotensin I in the blood, which could contribute to the development of atherosclerosis (43–45). This evidence concerns the gene ACE2 and atherosclerosis.